Protein biomarkers associated with acute renal failure and chronic kidney disease

被引:43
作者
Perco, P.
Pleban, C.
Kainz, A.
Lukas, A.
Mayer, G.
Mayer, B.
Oberbauer, R.
机构
[1] Krankenhaus Elisabethinen, A-4010 Linz, Austria
[2] Univ Vienna, Inst Theoret Chem, Vienna, Austria
[3] Emergentec Biodev GmbH, Vienna, Austria
[4] Med Univ Innsbruck, Dept Nephrol, Innsbruck, Austria
关键词
acute renal failure; biomarker; chronic kidney disease; protein discovery;
D O I
10.1111/j.1365-2362.2006.01729.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute renal failure (ARF) as well as chronic kidney disease (CKD) are currently categorized according to serum creatinine concentrations. Serum creatinine, however, has shortcomings because of its low predictive values. The need for novel markers for the early diagnosis and prognosis of renal diseases is imminent, particularly for markers reflecting intrinsic organ injury in stages when glomerular filtration is not impaired. This review summarizes protein markers discussed in the context of ARF as well as CKD, and provides an overview on currently available discovery results following 'omics' techniques. The identified set of candidate marker proteins is discussed in their cellular and functional context. The systematic review of proteomics and genomics studies revealed 56 genes to be associated with acute or chronic kidney disease. Context analysis, i.e. correlation of biological processes and molecular functions of reported kidney markers, revealed that 15 genes on the candidate list were assigned to the most significant ontology groups: immunity and defence. Other significantly enriched groups were cell communication (14 genes), signal transduction (22 genes) and apoptosis (seven genes). Among 24 candidate protein markers, nine proteins were also identified by gene expression studies. Next generation candidate marker proteins with improved diagnostic and prognostic values for kidney diseases will be derived from whole genome scans and protemics approaches. Prospective validation still remains elusive for all proposed candidates.
引用
收藏
页码:753 / 763
页数:11
相关论文
共 78 条
[31]   Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury [J].
Ichimura, T ;
Hung, CC ;
Yang, SA ;
Stevens, JL ;
Bonventre, JV .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 286 (03) :F552-F563
[32]   Alterations in gene expression in cadaveric vs. live donor kidneys suggest impaired tubular counterbalance of oxidative stress at implantation [J].
Kainz, A ;
Mitterbauer, C ;
Hauser, P ;
Schwarz, C ;
Regele, HM ;
Berlakovich, G ;
Mayer, G ;
Perco, P ;
Mayer, B ;
Meyer, TW ;
Oberbauer, R .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (10) :1595-1604
[33]   Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: A multicenter trial [J].
Kamijo, A ;
Sugaya, T ;
Hikawa, A ;
Yamanouchi, M ;
Hirata, Y ;
Ishimitsu, T ;
Numabe, A ;
Takagi, M ;
Hayakawa, H ;
Tabei, F ;
Sugimoto, T ;
Mise, N ;
Kimura, K .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2005, 145 (03) :125-133
[34]  
Kamijo Atsuko, 2003, Rinsho Byori, V51, P219
[35]   Increased resistin blood levels are not associated with insulin resistance in patients with renal disease [J].
Kielstein, JT ;
Becker, B ;
Graf, S ;
Brabant, G ;
Haller, H ;
Fliser, D .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (01) :62-66
[36]   Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog [J].
Kieran, NE ;
Doran, PP ;
Connolly, SB ;
Greenan, MC ;
Higgins, DF ;
Leonard, M ;
Godson, C ;
Taylor, CT ;
Henger, A ;
Kretzler, M ;
Burne, MJ ;
Rabb, H ;
Brady, HR .
KIDNEY INTERNATIONAL, 2003, 64 (02) :480-492
[37]   Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts [J].
Kwon, O ;
Molitoris, BA ;
Pescovitz, M ;
Kelly, KJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (05) :1074-1087
[38]  
Lameire N, 2005, LANCET, V365, P417
[39]   Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases? [J].
Lelongt, B ;
Legallicier, B ;
Piedagnel, R ;
Ronco, PN .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (01) :7-12
[40]  
Lenz O, 2000, J AM SOC NEPHROL, V11, P574, DOI 10.1681/ASN.V113574